These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 7235820

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Drug-induced torsade de pointes.
    Raehl CL, Patel AK, LeRoy M.
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide.
    Keren A, Tzivoni D, Gottlieb S, Benhorin J, Stern S.
    Chest; 1982 Mar; 81(3):384-6. PubMed ID: 7056119
    [Abstract] [Full Text] [Related]

  • 5. Torsade de pointes ventricular tachycardia. A complication of disopyramide shared with quinidine.
    Wald RW, Waxman MB, Colman JM.
    J Electrocardiol; 1981 Jul; 14(3):301-7. PubMed ID: 7264507
    [Abstract] [Full Text] [Related]

  • 6. Ventricular tachycardia-flutter associated with disopyramide therapy: a report of three cases.
    Dhurandhar RW, Nademanee K, Goldman AM.
    Heart Lung; 1978 Jul; 7(5):783-7. PubMed ID: 250503
    [Abstract] [Full Text] [Related]

  • 7. [Atypical ventricular tachycardia due to disopyramide].
    Feigl D, Ashkenazi J, Schwarzmann H.
    Harefuah; 1982 Mar 15; 102(6):246-7. PubMed ID: 7160719
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Paradoxic response to disopyramide and quinidine (author's transl)].
    Breithardt G, Seipel L, Haerten K.
    Z Kardiol; 1980 Aug 15; 69(8):556-61. PubMed ID: 7445656
    [Abstract] [Full Text] [Related]

  • 10. Ventricular pacing in atypical ventricular tachycardia.
    Keren A, Tzivoni D, Golhman JM, Corcos P, Benhorin J, Stern S.
    J Electrocardiol; 1981 Aug 15; 14(2):201-5. PubMed ID: 7276791
    [Abstract] [Full Text] [Related]

  • 11. Disopyramide-induced ventricular tachycardia.
    Lo KS, Gantz KB, Stetson PL, Lucchesi BR, Pitt B.
    Arch Intern Med; 1980 Mar 15; 140(3):413-4. PubMed ID: 6153888
    [Abstract] [Full Text] [Related]

  • 12. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
    Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH.
    JAMA; 1993 Dec 01; 270(21):2590-7. PubMed ID: 8230644
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A case series of drug-induced long QT syndrome and Torsade de Pointes.
    Tong KL, Lau YS, Teo WS.
    Singapore Med J; 2001 Dec 01; 42(12):566-70. PubMed ID: 11989578
    [Abstract] [Full Text] [Related]

  • 18. Ventricular tachyarrhythmias induced by disopyramide and other similar anti-arrhythmic drugs.
    Croft CH, Kennelly BM.
    S Afr Med J; 1981 Jun 06; 59(24):871-3. PubMed ID: 7233313
    [Abstract] [Full Text] [Related]

  • 19. Thioridazine-induced torsade de pointes. Successful therapy with isoproterenol.
    Kemper AJ, Dunlap R, Pietro DA.
    JAMA; 1983 Jun 03; 249(21):2931-4. PubMed ID: 6842807
    [Abstract] [Full Text] [Related]

  • 20. [Dangerous arrhythmias].
    Gertsch M, Fuhrer J.
    Schweiz Med Wochenschr; 1993 May 01; 123(17):833-43. PubMed ID: 8497770
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.